Evidence map›Paper›PMID 40290824›Full record

ArticleClinical diabetes : a publication of the American Diabetes Association2025

Clinical Need for Point-of-Care Testing for Diabetes in Clinical and Laboratory Improvement Amendments-Waived Settings.

Pamela R Kushner, Vivian Fonseca, James H Nichols, Jay H Shubrook, Eden Miller, Eugene Wright, Christopher DeFilippi, Joseph A Vassalotti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical diabetes : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pamela R KushnerUniversity of California, Irvine, Irvine, CA.ORCID https://orcid.org/0000-0002-5871-1265
Vivian FonsecaTulane University Health Sciences Center, New Orleans, LA.
James H NicholsDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Jay H ShubrookDepartment of Clinical Sciences and Community Health, Touro University California College of Osteopathic Medicine, Vallejo, CA.
Eden MillerDiabetes and Obesity Care, Bend, OR.
Eugene WrightDepartment of Medicine, Duke University Medical Center, Durham, NC.
Christopher DeFilippiInova Heart and Vascular Institute, Baltimore City County, MD.
Joseph A VassalottiNational Kidney Foundation, New York, NY.ORCID https://orcid.org/0000-0003-0275-0932

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point-of-care testing (POCT) has been used in multiple care settings for acute disease and, to a lesser extent, chronic disease testing. All POCT is regulated under the Clinical and Laboratory Improvement Amendments of 1988 (CLIA). CLIA-waived POCT requires no proficiency testing and can be carried out by nonlaboratory personnel. This review describes the benefits and limitations of POCT for cardiometabolic diseases and related conditions. It also explores the current U.S. regulatory environment for CLIA-waived POCT, highlighting the need for increased access.

Identifiers

PMID40290824
PMCPMC12019004

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.